Kratom Kulture Ultra Elite 7-OH Tablets 121mg – Maximum-Strength 7‑Hydroxymitragynine
Kratom Kulture Ultra Elite 7-OH Tablets 121mg are ultra‑high strength 7‑hydroxymitragynine tablets designed for experienced adult users who want concentrated 7‑OH in a compact, portionable format. Each tablet contains 121 mg of 7‑hydroxymitragynine, making this one of the strongest tablet formats in the Kratom Kulture lineup.
Key product details
- 121 mg of 7‑hydroxymitragynine per tablet in a compressed tablet format.
- Serving size: 1/4 tablet, reflecting the high potency and allowing more granular control over use.
- Tablets are scored so they can be split into smaller sections for flexible portioning.
- Manufactured without fillers, dyes, or artificial additives, focusing on stated alkaloid content only.
- Compact, discrete tablets packaged in a portable container for straightforward storage and on‑the‑go use.
- Scored design makes it easier to follow conservative serving guidelines (1/4 tablet) and avoid overuse.
- Intended for users already familiar with strong 7‑OH tablets and comfortable working with fractional servings.
Directions & responsible use
- Directions: Consult with a professional healthcare provider to determine if this product is appropriate and how to use it safely. Always start with a lower dose and only increase as advised.
- Do not take more than 1/2 tablet in a 24‑hour period due to the very high 7‑OH content.
- Serving size is 1/4 tablet; new users to this strength should remain at or below that level and wait adequate time before considering any additional use.
Safety, regulatory & disclaimer
As with all concentrated 7‑OH products, there is potential for habit formation and other risks; use should be cautious, infrequent, and guided by a healthcare professional where possible.
7‑hydroxymitragynine is not approved by the FDA as a dietary ingredient, and there are no FDA‑approved drugs containing this compound.
These products are not intended to diagnose, treat, cure, or prevent any disease, and statements have not been evaluated by the Food and Drug Administration.
US